Healthcare Contract Development & Manufacturing Organization Market by Services, End-User - Global Forecast 2025-2030- Product Image

Sale

Healthcare Contract Development & Manufacturing Organization Market by Services, End-User - Global Forecast 2025-2030

Report
189 Pages
October 2024
Region: Global
360iResearch™
ID: 5456956

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Healthcare Contract Development & Manufacturing Organization Market grew from USD 306.38 billion in 2023 to USD 331.99 billion in 2024. It is expected to continue growing at a CAGR of 8.84%, reaching USD 554.39 billion by 2030.

The Healthcare Contract Development & Manufacturing Organization (CDMO) market is a pivotal segment within the pharmaceutical and biotechnology industries, focusing on contracted services related to drug development and manufacturing. This market's scope includes comprehensive services ranging from R&D, clinical trials, process development, and scale-up, to commercial production of pharmaceutical products. These services are essential for pharmaceutical companies aiming to optimize resources, accelerate time-to-market, and mitigate the risks associated with in-house development. The application scope spans across small molecules, biologics, and specialty pharmaceuticals, with end-use industries including big pharma, small-to-mid-sized pharma, generic drug producers, and biotechs. Current market growth is substantially driven by the increasing demand for biologics, continuous innovation in drug modalities, and the need for more agile and specialized manufacturing capabilities. Key opportunities lie in areas such as cell and gene therapy, high-potency compounds, and biosimilars, where technological advancements and niche expertise offer significant competitive advantages. However, the market faces challenges including stringent regulatory norms, quality assurance complexities, and high capital investment requirements which can influence growth dynamics. Emerging markets are offering substantial potential due to cost advantages and expanding local patient bases. For CDMOs, collaborations and strategic partnerships are recommended to leverage technological advancements and enhance service portfolios. The best areas for innovation include adopting continuous manufacturing processes, integrating digitalization and data analytics for process optimization, and enhancing capabilities in personalized medicine manufacturing. The market is characterized by its highly fragmented nature, with numerous players offering specialized services, and a trend towards consolidation is being observed as companies seek to increase their service offerings and global footprint. Balancing innovation with stringent compliance and quality standards will be crucial for companies looking to capitalize on this market's dynamic and evolving landscape.

Understanding Market Dynamics in the Healthcare Contract Development & Manufacturing Organization Market

The Healthcare Contract Development & Manufacturing Organization Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing demand for biologics with increasing prevalence of chronic diseases
- Rising complex healthcare treatments with the reliance on advanced manufacturing capabilities
Market Restraints
- High operational costs of healthcare CDMO services
Market Opportunities
- Adoption of innovative technologies that enhance the efficiency of CDMO services
- Strategic partnerships with biotech firms for CDMO services
Market Challenges
- Stringent regulatory scrutiny for CDMO services

Exploring Porter’s Five Forces for the Healthcare Contract Development & Manufacturing Organization Market

Porter’s Five Forces framework further strengthens the insights of the Healthcare Contract Development & Manufacturing Organization Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Healthcare Contract Development & Manufacturing Organization Market

External macro-environmental factors deeply influence the performance of the Healthcare Contract Development & Manufacturing Organization Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Healthcare Contract Development & Manufacturing Organization Market

The Healthcare Contract Development & Manufacturing Organization Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Healthcare Contract Development & Manufacturing Organization Market

The Healthcare Contract Development & Manufacturing Organization Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Healthcare Contract Development & Manufacturing Organization Market

The Healthcare Contract Development & Manufacturing Organization Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Development & Manufacturing Organization Market, highlighting leading vendors and their innovative profiles. These include Baxter International, Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent Inc., Charles River Laboratories International, Inc., Corden Pharma International GmbH, Curia Global, Inc., Eurofins Scientific SE, EVER company group, Evonik Industries AG, FUJIFILM Diosynth Biotechnologies, Jabil, Inc., Laboratory Corporation of America Holdings, Lonza Group AG, MedPharm Ltd., Merck KGaA, Piramal Group, Porton Pharma Solutions Ltd, Recipharm AB, Samsung Biologics, Sanmina Corporation, Siegfried Holding AG, Siegfried-Group, Thermo Fisher Scientific, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Development & Manufacturing Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
- Contract development
  - Large Molecule
    - Cell Line development
    - Process Development
  - Small Molecule
    - Clinical
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Laboratory Services
      - Analytical Services
      - Bioanalytical Services
    - Preclinical
      - Bioanalysis and DMPK studies
      - Other Preclinical Services
      - Toxicology Testing
- Contract manufacturing
  - Finished Dose Formulations
  - High Potency API
  - Large Molecule
  - Medical Devices
  - Small Molecule
End-User
- Big Pharmaceutical Companies
- Generic Pharmaceutical Companies
- Small & Medium-Sized Pharmaceutical Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for biologics with increasing prevalence of chronic diseases
5.1.1.2. Rising complex healthcare treatments with the reliance on advanced manufacturing capabilities
5.1.2. Restraints
5.1.2.1. High operational costs of healthcare CDMO services
5.1.3. Opportunities
5.1.3.1. Adoption of innovative technologies that enhance the efficiency of CDMO services
5.1.3.2. Strategic partnerships with biotech firms for CDMO services
5.1.4. Challenges
5.1.4.1. Stringent regulatory scrutiny for CDMO services
5.2. Market Segmentation Analysis
5.2.1. Services: Growing usage of finished dose formulations with the focus on specialty medicine and biologics
5.2.2. End-User: Rising adoption of CDMO services by big pharmaceutical companies to support large-scale clinical and commercial manufacturing
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Healthcare Contract Development & Manufacturing Organization Market, by Services

6.1. Introduction
6.2. Contract development
6.2.1. Large Molecule
6.2.1.1. Cell Line development
6.2.1.2. Process Development
6.2.2. Small Molecule
6.2.2.1. Clinical
6.2.2.1.1. Phase I
6.2.2.1.2. Phase II
6.2.2.1.3. Phase III
6.2.2.1.4. Phase IV
6.2.2.2. Laboratory Services
6.2.2.2.1. Analytical Services
6.2.2.2.2. Bioanalytical Services
6.2.2.3. Preclinical
6.2.2.3.1. Bioanalysis and DMPK studies
6.2.2.3.2. Other Preclinical Services
6.2.2.3.3. Toxicology Testing
6.3. Contract manufacturing
6.3.1. Finished Dose Formulations
6.3.2. High Potency API
6.3.3. Large Molecule
6.3.4. Medical Devices
6.3.5. Small Molecule

7. Healthcare Contract Development & Manufacturing Organization Market, by End-User

7.1. Introduction
7.2. Big Pharmaceutical Companies
7.3. Generic Pharmaceutical Companies
7.4. Small & Medium-Sized Pharmaceutical Companies

8. Americas Healthcare Contract Development & Manufacturing Organization Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Healthcare Contract Development & Manufacturing Organization Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. FUJIFILM Corporation Invests USD 1.2 Billion to Expand Biotech Facility in Holly Springs
11.3.2. Fujirebio Holdings and Agappe Diagnostics Form CDMO Partnership for Local Chemiluminescence Solution Production
11.3.3. Enzene Biosciences Establishes First U.S. Manufacturing Site to Boost Biotech Partnerships and Market Presence
11.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET RESEARCH PROCESS
FIGURE 2. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET DYNAMICS
TABLE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY OTHER PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY HIGH POTENCY API, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 71. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 72. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 73. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 74. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 75. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 77. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 78. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 80. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 81. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 84. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 87. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 119. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 120. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 121. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 122. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 124. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 125. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 127. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 128. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 129. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 130. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 131. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 132. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 133. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 134. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 145. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 146. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 147. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 148. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 149. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 151. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 152. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 200. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 201. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 202. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 203. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 205. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 206. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 226. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 227. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 228. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 231. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 233. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 234. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 236. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 237. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
TABLE 238. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
TABLE 239. E

Companies Mentioned

The leading players in the Healthcare Contract Development & Manufacturing Organization market, which are profiled in this report, include:

Baxter International, Inc.
Boehringer Ingelheim International GmbH
Cambrex Corporation
Catalent Inc.
Charles River Laboratories International, Inc.
Corden Pharma International GmbH
Curia Global, Inc.
Eurofins Scientific SE
EVER company group
Evonik Industries AG
FUJIFILM Diosynth Biotechnologies
Jabil, Inc.
Laboratory Corporation of America Holdings
Lonza Group AG
MedPharm Ltd.
Merck KGaA
Piramal Group
Porton Pharma Solutions Ltd
Recipharm AB
Samsung Biologics
Sanmina Corporation
Siegfried Holding AG
Siegfried-Group
Thermo Fisher Scientific, Inc.
WuXi AppTec

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 331.99 Billion
Forecasted Market Value ( USD ) by 2030	$ 554.39 Billion
Compound Annual Growth Rate	8.8%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Healthcare Contract Development & Manufacturing Organization Market

Exploring Porter’s Five Forces for the Healthcare Contract Development & Manufacturing Organization Market

Applying PESTLE Analysis to the Healthcare Contract Development & Manufacturing Organization Market

Analyzing Market Share in the Healthcare Contract Development & Manufacturing Organization Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Healthcare Contract Development & Manufacturing Organization Market

Strategic Recommendations for Success in the Healthcare Contract Development & Manufacturing Organization Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region (Europe, APAC), And Segment Forecasts, 2024 - 2030

Healthcare Contract Development and Manufacturing Organization - Global Strategic Business Report

Biologics Contract Development & Manufacturing Organization Market by Type, Product Type, Disease Indication, Service Type, End-User - Global Forecast 2025-2030

mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Application, Indication, End-use, Region, and Segment Forecasts, 2024-2030

Small Molecules Innovator Contract Development And Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)